Invention Grant
- Patent Title: Cells for producing recombinant iduronate-2-sulfatase
-
Application No.: US14832728Application Date: 2015-08-21
-
Publication No.: US09719074B2Publication Date: 2017-08-01
- Inventor: Ferenc Boldog , Michael Heartlein
- Applicant: Shire Human Genetic Therapies, Inc.
- Applicant Address: US MA Lexington
- Assignee: Shire Human Genetic Therapies, Inc.
- Current Assignee: Shire Human Genetic Therapies, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Proskauer Rose LLP
- Agent Fangli Chen; Julio J. Mendez
- Main IPC: C12N9/16
- IPC: C12N9/16

Abstract:
The present invention provides, among other things, methods and compositions for production of recombinant I2S protein with improved potency and activity using cells co-express I2S and FGE protein. In some embodiments, cells according to the present invention are engineered to simultaneously over-express recombinant I2S and FGE proteins. Cells according to the invention are adaptable to various cell culture conditions. In some embodiments, cells of the present invention adaptable to a large-scale suspension serum-free culture.
Public/Granted literature
- US20160053238A1 CELLS FOR PRODUCING RECOMBINANT IDURONATE-2-SULFATASE Public/Granted day:2016-02-25
Information query